Chulhee Choi

President @ ILIAS Biologics Inc.

About

As a professor at KAIST, I have been studying the cellular and molecular mechanisms for human diseases such as brain cancers and chronic inflammatory disorders. Recently, my team has developed a novel exosome-based drug delivery platform technology called EXPLOR (exosome engineering for protein loading via optically reversible protein interaction). To further develop this EXPLOR technology as new biopharmaceuticals, I have founded ILIAS Biologics Inc. (previously, Cellex Life Sciences Inc.)

Country

South Korea

City

Daejeon

Industry

Biotechnology

Skill

Exosome Engineering, Biophotonics, Cell Signaling, 과학, 분자생물학, 리서치, 세포배양, 세포생물학, 강의, 생명과학

Experience

President

ILIAS Biologics Inc.

2015-11 - Present · 10 yrs 11 mos

Daejeon, South Korea

At ILIAS Biologics, we dedicate ourselves to the development of paradigm-shifting advances in human medicine. Exosomes, extracellular vesicles naturally released by cells, represent such an opportunity thanks to its unique ability to deliver biological information between cells. Our platform technology, EXPLOR®, makes it possible to load large therapeutic molecules into exosomes, and we are actively developing various therapeutic exosomes, Exo-Targets®, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas. To learn more, please visit our website http://www.iliasbio.com or email us at BD@iliasbio.com